Last reviewed · How we verify
Whole Egg
At a glance
| Generic name | Whole Egg |
|---|---|
| Sponsor | Penn State University |
| Drug class | Nutritional supplement |
| Target | Nutritional support |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
Common side effects
- Wheal and erythema reactions
- Sneezing
- Urticaria
- Itching
- Edema
Serious adverse events
- Anaphylactic symptoms
- Systemic reaction
- Wheezing
- Asthma
- Dyspnea
- Cyanosis
- Hypotension
- Syncope
- Upper airway obstruction
- Shock
Key clinical trials
- Dairy Choline Bioavailability (NA)
- Nutrition for Precision Health, Powered by the All of Us (NA)
- Child Health, Agriculture and Integrated Nutrition (NA)
- Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study (PHASE1)
- Effect of Mediterranean vs Paleolithic Diet on RA Activity, Sarcopenia and QOL: 12-Week RCT (NA)
- Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome (NA)
- Investigation of the Effect of the MIND Diet on Disease Symptoms in Patients With MS (NA)
- Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Whole Egg CI brief — competitive landscape report
- Whole Egg updates RSS · CI watch RSS
- Penn State University portfolio CI